Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (71-80 of 721) with videos related to

Pageof 73
Sort By:
Nuklearmedizin. Nuclear Medicine|December 18, 2020
"COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty" based on a report of Prof. Dr. Ignasi CarrioIgnasi Carrio, Markus Essler, Lutz S Freudenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Design Considerations in the PSMAfore TrialOliver Sartor, Karim Fizazi, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
Green Nuclear Medicine and RadiotheranosticsPatrick Veit-Haibach, Ken Herrmann, Richard Zimmermann, et al.
Expert Review of Molecular Diagnostics|September 30, 2016
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancerMartin Barrio, Wolfgang P Fendler, Johannes Czernin, et al.
Seminars in Nuclear Medicine|August 10, 2020
Molecular Imaging and Therapy of Colorectal and Anal CancerPatrick Sandach, Stefan Kasper-Virchow, Christoph Rischpler, et al.
European Urology Oncology|November 25, 2022
Positive Prostate-specific Membrane Antigen Findings: How To Interpret ThemKelsey L Pomykala, Ken Herrmann, Elisabetta Lalumera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2021
Hybrid total-body pet scanners-current status and future perspectivesVanessa Nadig, Ken Herrmann, Felix M Mottaghy, et al.
Nuclear Medicine Communications|April 6, 2016
Have we overcome choline PET/CT for early detection of prostate cancer recurrence?Wolfgang P Fendler, Christina Bluemel, Domenico Rubello, et al.
Gastrointestinal Cancer Research : GCR|March 5, 2009
The Value of PET Imaging in Patients with Localized Gastroesophageal CancerKatja Ott, Ken Herrmann, Bernd-Joachim Krause, et al.
Expert Review of Medical Devices|February 16, 2016
3D scintigraphic imaging and navigation in radioguided surgery: freehand SPECT technology and its clinical applicationsChristina Bluemel, Philipp Matthies, Ken Herrmann, et al.
Pageof 73

Showing results (71-80 of 721) with videos related to

Sort By:
Pageof 73
Nuklearmedizin. Nuclear Medicine|December 18, 2020
"COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty" based on a report of Prof. Dr. Ignasi CarrioIgnasi Carrio, Markus Essler, Lutz S Freudenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Design Considerations in the PSMAfore TrialOliver Sartor, Karim Fizazi, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
Green Nuclear Medicine and RadiotheranosticsPatrick Veit-Haibach, Ken Herrmann, Richard Zimmermann, et al.
Expert Review of Molecular Diagnostics|September 30, 2016
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancerMartin Barrio, Wolfgang P Fendler, Johannes Czernin, et al.
Seminars in Nuclear Medicine|August 10, 2020
Molecular Imaging and Therapy of Colorectal and Anal CancerPatrick Sandach, Stefan Kasper-Virchow, Christoph Rischpler, et al.
European Urology Oncology|November 25, 2022
Positive Prostate-specific Membrane Antigen Findings: How To Interpret ThemKelsey L Pomykala, Ken Herrmann, Elisabetta Lalumera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2021
Hybrid total-body pet scanners-current status and future perspectivesVanessa Nadig, Ken Herrmann, Felix M Mottaghy, et al.
Nuclear Medicine Communications|April 6, 2016
Have we overcome choline PET/CT for early detection of prostate cancer recurrence?Wolfgang P Fendler, Christina Bluemel, Domenico Rubello, et al.
Gastrointestinal Cancer Research : GCR|March 5, 2009
The Value of PET Imaging in Patients with Localized Gastroesophageal CancerKatja Ott, Ken Herrmann, Bernd-Joachim Krause, et al.
Expert Review of Medical Devices|February 16, 2016
3D scintigraphic imaging and navigation in radioguided surgery: freehand SPECT technology and its clinical applicationsChristina Bluemel, Philipp Matthies, Ken Herrmann, et al.
Pageof 73